Skip to main content
Terug
Watch Compare

Aura Biosciences, Inc.

Datakwaliteit: 83%
AURA
Nasdaq Manufacturing Chemicals
€ 6,78
▲ € 0,01 (0,07%)
Marktkapitalisatie: 434,62 M
Prijs
€ 6,78
Marktkapitalisatie
434,62 M
Dagbereik
€ 6,59 — € 6,95
52-Weeksbereik
€ 4,35 — € 7,48
Volume
183.041
Openen € 6,72
50D / 200D Gem.
€ 5,94
14,08% above
50D / 200D Gem.
€ 6,09
11,17% above

Quick Summary

Belangrijkste Punten

Negative free cash flow of -85,19 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-64,11%
Onder sectorgemiddelde (-53,47%)
ROIC-49,40%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio9,04
Interest CoverageN/A

Waardering

PE (TTM)
-4,09
Onder sectorgemiddelde (-1,47)
P/B Ratio2,77
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -4,1 -1,5
P/B 2,8 1,6
ROE % -64,1 -53,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

ETFs Holding This Stock

HAUZ logo HAUZ Xtrackers International Real Estate ETF
0,10% weight
AVDS logo AVDS Avantis International Small Cap Equity ETF
0,04% weight
WMRIX WMRIX
0,02% weight
WMMRX WMMRX
0,02% weight
AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0,02% weight
AVSD logo AVSD Avantis Responsible International Equity ETF
0,01% weight
IRSSX IRSSX
0,01% weight
IIRSX IIRSX
0,01% weight
IRSIX IRSIX
0,01% weight
IRCIX IRCIX
0,01% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -106,19 M
ROE -64,11% ROA -53,85%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -85,19 M
ROIC -49,40% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 9,04
Interest Coverage N/A Asset Turnover N/A
Working Capital 151,30 M Tangible Book Value 156,67 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4,09 Forward P/E N/A
P/B Ratio 2,77 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -19,60%
Market Cap 434,62 M Enterprise Value 387,07 M
Per Share
EPS (Diluted TTM) -1,76 Revenue / Share N/A
FCF / Share -1,33 OCF / Share -1,32
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 80,22%
SBC-Adj. FCF -98,97 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -106,19 M -86,92 M -76,41 M -58,76 M -35,25 M
EPS (Diluted) -1,76 -1,75 -1,93 -1,96 —
Gross Profit — — — — —
Operating Income -112,79 M -96,12 M -84,99 M -60,30 M -35,25 M
EBITDA — — — — —
R&D Expenses 90,30 M 73,30 M 65,23 M 42,24 M 25,16 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — — — — —
Income Tax 108.000,0 112.000,0 137.000,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 169,43 M 182,50 M 255,08 M 223,94 M 160,03 M
Total Liabilities 32,52 M 30,53 M 29,23 M 28,35 M 7,72 M
Shareholders' Equity 136,91 M 151,97 M 225,85 M 195,58 M 152,32 M
Total Debt — — — — —
Cash & Equivalents 59,52 M 31,69 M 41,06 M 121,58 M 149,06 M
Current Assets 149,74 M 160,62 M 231,79 M 196,70 M 153,70 M
Current Liabilities 18,38 M 14,91 M 12,36 M 10,46 M 7,27 M